Published in N Engl J Med on January 29, 1981
Alternative RNA processing events in human calcitonin/calcitonin gene-related peptide gene expression. Proc Natl Acad Sci U S A (1985) 1.62
The pathobiology of the osteoclast. J Clin Pathol (1985) 1.48
Expression of the human calcitonin/CGRP gene in lung and thyroid carcinoma. EMBO J (1985) 1.39
Tumour markers: An overview. Indian J Clin Biochem (2007) 1.26
Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment. J Clin Invest (1988) 1.22
The construction and partial characterization of plasmids containing complementary DNA sequences to human calcitonin precursor polyprotein. Biochem J (1981) 1.07
NMR characterization of monomeric and oligomeric conformations of human calcitonin and its interaction with EGCG. J Mol Biol (2011) 0.95
Conformational transitions and fibrillation mechanism of human calcitonin as studied by high-resolution solid-state 13C NMR. Protein Sci (2000) 0.93
Postoperative tetany in Graves disease: important role of vitamin D metabolites. Ann Surg (1999) 0.92
Hypercalcemia of Malignancy: An Update on Pathogenesis and Management. N Am J Med Sci (2015) 0.90
Differential utilization of calcitonin gene regulatory DNA sequences in cultured lines of medullary thyroid carcinoma and small-cell lung carcinoma. Mol Cell Biol (1990) 0.89
The unique endocrine milieu of the fetus. J Clin Invest (1986) 0.87
Preprocalcitonin signal peptide generates a cytotoxic T lymphocyte-defined tumor epitope processed by a proteasome-independent pathway. Proc Natl Acad Sci U S A (2008) 0.85
Discovery of alpha-Klotho unveiled new insights into calcium and phosphate homeostasis. Proc Jpn Acad Ser B Phys Biol Sci (2009) 0.84
Effects of heparin, histamine, and salmon calcitonin on mouse calvarial bone resorption. Ann Rheum Dis (1986) 0.83
Anti-nociceptive effects of elcatonin injection for postmenopausal women with back pain: a randomized controlled trial. Open Orthop J (2010) 0.82
Conformational flexibility in calcitonin: the dynamic properties of human and salmon calcitonin in solution. J Biomol NMR (1999) 0.81
Voltage-gated sodium and potassium currents and their variation in calcitonin-secreting cells of the chick. J Physiol (1988) 0.81
Somatostatin: a paracrine contribution to hypothyroidism in Hashimoto's thyroiditis. J Clin Pathol (1982) 0.79
Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma. J Clin Endocrinol Metab (2008) 0.79
Wnt-signaling-mediated antiosteoporotic activity of porcine placenta hydrolysates in ovariectomized rats. Evid Based Complement Alternat Med (2012) 0.79
Immunocytochemical Localization of Prohormone Convertase 1/3 and 2 in Thyroid C-Cells and Medullary Thyroid Carcinomas. Endocr Pathol (2000) 0.78
Calcitonin substitution in calcitonin deficiency reduces particle-induced osteolysis. BMC Musculoskelet Disord (2011) 0.78
Renal effects of gastrin C-terminal tetrapeptide (as pentagastrin) and cholecystokinin octapeptide in conscious rabbit and man. Br J Pharmacol (1987) 0.76
Management of endocrine disorders in pregnancy Part I--thyroid and parathyroid disease. Postgrad Med J (1984) 0.75
Paget's disease of bone. West J Med (1984) 0.75
Unmasking of primary hyperparathyroidism by Vitamin D therapy. Indian J Nephrol (2015) 0.75
Oncological emergencies associated with gastrointestinal tumors. Ann Gastroenterol (2015) 0.75
Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community. N Engl J Med (1980) 4.96
Interaction of chemokine receptor CCR5 with its ligands: multiple domains for HIV-1 gp120 binding and a single domain for chemokine binding. J Exp Med (1997) 3.48
HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet (2002) 3.07
Bacteriochlorophyll-protein complexes from the light-harvesting antenna of photosynthetic bacteria. Biochemistry (1978) 1.89
C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential. J Immunol (2001) 1.71
Parathyroid hormone-related peptide in plasma of patients with hypercalcemia and malignant lesions. Mayo Clin Proc (1990) 1.56
Genetic abnormalities in sporadic parathyroid adenomas: loss of heterozygosity for chromosome 3q markers flanking the calcium receptor locus. J Clin Endocrinol Metab (1995) 1.40
Anonymity rights. Br Dent J (2010) 1.39
Living environments and older people. Nurs Older People (2000) 1.38
Serum ionized calcium during bed rest in fracture patients and normal men. Metabolism (1972) 1.32
Plasma calcitonin in normal man. Differences between men and women. J Clin Invest (1977) 1.28
Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion. Neuropharmacology (1991) 1.28
Familial benign hypercalcemia (hypocalciuric hypercalcemia). Clinical and pathogenetic studies in 21 families. Ann Intern Med (1985) 1.27
Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas. J Clin Endocrinol Metab (1996) 1.24
Persistently elevated parathyroid hormone secretion and action in young women after four weeks of ingesting high phosphorus, low calcium diets. J Clin Endocrinol Metab (1990) 1.23
The development of retinopathy in sucrose-fed and streptozotocin-diabetic rats. Diabetologia (1976) 1.22
Behavioral assessment of Alzheimer's transgenic mice following long-term Abeta vaccination: task specificity and correlations between Abeta deposition and spatial memory. DNA Cell Biol (2001) 1.22
Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials. Arch Intern Med (2000) 1.17
Impaired vitamin D metabolism with aging in women. Possible role in pathogenesis of senile osteoporosis. J Clin Invest (1984) 1.15
Platelet adhesiveness and aggregation in relation to diabetic retinopathy. Diabetologia (1971) 1.15
Epidemiology of medullary carcinoma of the thyroid gland: a 5-year experience (1971-1976). Surg Clin North Am (1977) 1.06
Elevated secretion and action of serum parathyroid hormone in young adults consuming high phosphorus, low calcium diets assembled from common foods. J Clin Endocrinol Metab (1988) 1.05
Risk of age-related fractures in patients with primary hyperparathyroidism. Arch Intern Med (1992) 1.00
Calcium infusion suggests a "set-point" abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism. J Clin Endocrinol Metab (1993) 0.99
An update on the vitamin D content of fortified milk from the United States and Canada. N Engl J Med (1993) 0.98
Calcium homeostasis in diabetes mellitus. J Clin Endocrinol Metab (1979) 0.96
Hyperparathyroidism-jaw tumor syndrome: the HRPT2 locus is within a 0.7-cM region on chromosome 1q. Am J Hum Genet (1999) 0.96
Diabetes mellitus and risk of skeletal fracture. N Engl J Med (1980) 0.95
Therapeutic radiation and hyperparathyroidism. A case-control study in Rochester, Minn. Arch Intern Med (1989) 0.95
Differential effects of parathyroid hormone and its analogues on cytosolic calcium ion and cAMP levels in cultured rat osteoblast-like cells. J Biol Chem (1988) 0.95
Orthophosphate therapy decreases urinary calcium excretion and serum 1,25-dihydroxyvitamin D concentrations in idiopathic hypercalciuria. J Clin Endocrinol Metab (1980) 0.94
Evaluation of the mutagenic potential of mycotoxins using Salmonella typhimurium and Saccharomyces cerevisiae. Mutat Res (1978) 0.94
Autosomal recessive inheritance of familial hyperparathyroidism. N Engl J Med (1983) 0.93
The sorbitol pathway: effect of streptozotocin induced diabetes and the feeding of a sucrose-rich diet on glucose, sorbitol and fructose in the retina, blood and liver of rats. Diabetologia (1976) 0.92
Axial and appendicular bone mineral density in patients with long-term deficiency or excess of calcitonin. N Engl J Med (1987) 0.91
Glucose, glucose-6-phosphate, lactate and pyruvate content of the retina, blood and liver of streptozotocin-diabetic rats fed sucrose- or starch-rich diets. Diabetologia (1975) 0.91
Non-suppressible parathyroid hormone secretion is related to gland size in uremic secondary hyperparathyroidism. Kidney Int (1996) 0.91
Calcium regulation of parathyroid and C cell function in familial benign hypercalcemia. J Bone Miner Res (1991) 0.90
Production, degradation, and circulating levels of 1,25-dihydroxyvitamin D in health and in chronic glucocorticoid excess. J Clin Invest (1980) 0.89
Calcitonin secretion in postmenopausal osteoporosis. N Engl J Med (1985) 0.89
Serum calcitonin and parathyroid hormone in experimental diabetes: effects of insulin treatment. Endocrinology (1978) 0.89
Urinary cyclic 3',5'-adenosine monophosphate responses to exogenous and endogenous parathyroid hormone in familial benign hypercalcemia and primary hyperparathyroidism. J Lab Clin Med (1980) 0.88
Plasma intact parathyroid hormone (PTH) and PTH-related peptide in familial benign hypercalcemia: greater responsiveness to endogenous PTH than in primary hyperparathyroidism. J Clin Endocrinol Metab (1991) 0.88
A gastric factor, calcitonin, and the hypocalcemia induced by gastrointestinal hormones. Endocrinology (1979) 0.87
The effect of beta,beta'-iminodipropionitrile and anaesthesia on some adenine nucleotides of rat brain and retina. J Neurochem (1968) 0.87
Retinal angiopathy in the imino-dipropionitrile-treated alloxan-diabetic rat. Br J Exp Pathol (1966) 0.87
Do tissues other than the kidney produce 1,25-dihydroxyvitamin D3 in vivo? A reexamination. Proc Natl Acad Sci U S A (1983) 0.87
Identification of fructose as the retinopathic agent associated with the ingestion of sucrose-rich diets in the rat. Metabolism (1980) 0.86
Distribution of serum calcium values in patients with familial benign hypercalcemia (hypocalciuric hypercalcemia): evidence for a discrete genetic defect. J Clin Endocrinol Metab (1987) 0.86
Determination of silica-purified plasma calcitonin for the detection and management of medullary thyroid carcinoma: comparison of two provocative tests. Mayo Clin Proc (1987) 0.85
The effect of beta,beta'-iminodipropionitrile treatment and alloxan diabetes on the glycosaminoglycans of the rat retina and aorta. Biochim Biophys Acta (1967) 0.85
Changes in the hydroxyproline, hexosamine and sialic acid of the diabetic human and beta, beta'-iminodipropionitrile-treated rat retinal vascular systems. Diabetologia (1967) 0.85
Visual acuity after successful treatment of large macular retinoblastoma. J Pediatr Ophthalmol Strabismus (1992) 0.85
Comparison of the effects of pentagastrin and meal-stimulated gastrin on plasma calcitonin in normal man. Am J Dig Dis (1978) 0.85
Hypocalcemic emergencies. Med Clin North Am (1995) 0.85
Chemical changes in human diabetic, cataractous and beta,beta'-iminodipropionitrile-treated rat lens capsules. Exp Eye Res (1967) 0.85
Effect of age on circulating immunoreactive and bioactive parathyroid hormone levels in women. J Bone Miner Res (1987) 0.84
Multiple endocrine neoplasia in a dog. J Am Vet Med Assoc (1982) 0.84
Preoperative diagnosis of occult parathyroid hyperplasia by calcium infusion in patients with multiple endocrine neoplasia, type 2a. J Clin Endocrinol Metab (1976) 0.84
Parathyroid glands in familial benign hypercalcemia (familial hypocalciuric hypercalcemia). Am J Med (1984) 0.84
Hyperphosphatemic tumoral calcinosis: effects of phosphate depletion on vitamin D metabolism, and of acute hypocalcemia on parathyroid hormone secretion and action. J Clin Endocrinol Metab (1983) 0.84
Biologic markers in cancer diagnosis and treatment. Curr Probl Cancer (1981) 0.84
The parathyroid glands in multiple endocrine neoplasia type 2b. Am J Pathol (1980) 0.84
Pre- and postoperative studies of plasma calcitonin in primary hyperparathyroidism. J Clin Invest (1979) 0.83
Mechanism of action of estrogens and selective estrogen receptor modulators. Vitam Horm (2000) 0.83
Reduced-volume radioimmunoassays for parathyrin and calcitonin in serum, for use in pediatric and small-animal studies. Clin Chem (1978) 0.83
Transwell chemotaxis. Methods Mol Biol (2000) 0.83
Acute effects of oral phosphate-salt ingestion on serum phosphorus, serum ionized calcium, and parathyroid hormone in young adults. Am J Clin Nutr (1988) 0.83
Failure of cimetidine to affect calcium homeostasis in familial primary hyperparathyroidism (multiple endocrine neoplasia, type 1). J Clin Endocrinol Metab (1980) 0.83
Bone mineral density and skeletal fractures in familial benign hypercalcemia (hypocalciuric hypercalcemia). Mayo Clin Proc (1984) 0.83
Adrenal insufficiency resulting from metastasis of non-functioning adrenocortical carcinoma. Med Ann Dist Columbia (1973) 0.82
Increased renal responses to exogenous parathyroid hormone in postsurgical hypoparathyroidism. J Clin Endocrinol Metab (1984) 0.82
Athletic women, amenorrhea, and skeletal integrity. Ann Intern Med (1985) 0.81
Idiopathic acquired diffuse osteosclerosis in a young woman. J Bone Miner Res (1990) 0.80
The "calcium clamp": effect of constant hypocalcemia on parathyroid hormone secretion. Am J Physiol (1981) 0.80
Vitamin D metabolism in familial benign hypercalcemia (hypocalciuric hypercalcemia) differs from that in primary hyperparathyroidism. J Clin Endocrinol Metab (1984) 0.80
Hypercalcemia. Endocrinol Metab Clin North Am (1988) 0.80
Biogenic amines and the secretion of parathyroid hormone and calcitonin. Endocr Rev (1980) 0.80
Epinephrine is a hypophosphatemic hormone in man. Physiological effects of circulating epinephrine on plasma calcium, magnesium, phosphorus, parathyroid hormone, and calcitonin. J Clin Invest (1983) 0.80
The effect of O-(beta-hydroxyethyl) rutoside on platelet intermediary metabolism in normal and streptozotocin diabetic rats. Biochem Pharmacol (1974) 0.80
Clinically useful calcitonin assays. Trends Endocrinol Metab (2008) 0.79
High-resolution parathyroid ultrasonography in familial benign hypercalcemia (familial hypocalciuric hypercalcemia). Mayo Clin Proc (1984) 0.79
Excess post-exercise oxygen consumption in untrained men following exercise of equal energy expenditure: comparisons of upper and lower body exercise. Diabetes Obes Metab (2007) 0.79
The effects of an aldose reductase inhibitor upon the sorbitol pathway, fructose-1-phosphate and lactate in the retina and nerve of streptozotocin-diabetic rats. Exp Eye Res (1983) 0.79
Pheochromocytoma associated with hypercalcemia and ectopic secretion of calcitonin. Ann Intern Med (1979) 0.79
Chromosomal localization of the parathyroid hormone/parathyroid hormone-related protein receptor gene to human chromosome 3p21.1-p24.2. J Clin Endocrinol Metab (1994) 0.79
Secretion and metabolism of monomeric human calcitonin: effects of age, sex, and thyroid damage. J Bone Miner Res (1986) 0.79
Time- and dose-related biphasic effects of synthetic bovine parathyroid hormone fragment 1-34 on urinary cation excretion. J Clin Endocrinol Metab (1984) 0.79
Ultrastructural alterations during the development of retinopathy in sucrose-fed and streptozotocin-diabetic rats. Exp Eye Res (1977) 0.79
Estimates of circulating monomeric calcitonin: physiological studies in normal and thyroidectomized man. J Clin Endocrinol Metab (1983) 0.79
Asymptomatic primary hyperparathyroidism: treat or follow? Mayo Clin Proc (1981) 0.79
Calcium, magnesium, and phosphorus metabolism in dogs given intravenous triacetin. Am J Clin Nutr (1989) 0.79
Regulation of calcitonin secretion in normal man by changes of serum calcium within the physiologic range. J Clin Invest (1979) 0.79
Cimetidine treatment of azotemic secondary hyperparathyroidism. J Clin Endocrinol Metab (1982) 0.78
Inhibition of alcohol dehydrogenase by chloroquine. Nature (1967) 0.78
Parathyroid hormone does not increase nephrogenous cyclic AMP excretion by the dog. Endocrinology (1980) 0.77
Cyclic adenosine 3',5'-monophosphate responses to parathyroid hormone, prostaglandin E2, and isoproterenol in dermal fibroblasts from patients with familial benign hypercalcemia. J Clin Endocrinol Metab (1991) 0.77
Diffuse osteosclerosis in intravenous drug abusers. Am J Med (1993) 0.77
Effects of altered calcium intake on diurnal and calcium-stimulated plasma calcitonin in normal women. J Bone Miner Res (1989) 0.77